These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19816157)

  • 1. Adherence characteristics after abnormal screening results between mammogram and Papanicolaou test groups.
    Fang SY; Shu BC
    Cancer Nurs; 2009; 32(6):437-45. PubMed ID: 19816157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processes of care in cervical and breast cancer screening and follow-up--the importance of communication.
    Zapka JG; Puleo E; Taplin SH; Goins KV; Ulcickas Yood M; Mouchawar J; Somkin C; Manos MM
    Prev Med; 2004 Jul; 39(1):81-90. PubMed ID: 15207989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
    J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.
    Martinez-Huedo MA; Lopez de Andres A; Hernandez-Barrera V; Carrasco-Garrido P; Martinez Hernandez D; Jiménez-Garcia R
    Diabetes Metab; 2012 Apr; 38(2):142-8. PubMed ID: 22078638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations in breast and colon cancer screening behavior in women.
    Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ
    Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.
    Yabroff KR; Breen N; Vernon SW; Meissner HI; Freedman AN; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):723-32. PubMed ID: 15159302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What predicts adherence to follow-up recommendations for abnormal Pap tests among older women?
    Coker AL; Eggleston KS; Meyer TE; Luchok K; Das IP
    Gynecol Oncol; 2007 Apr; 105(1):74-80. PubMed ID: 17157363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast and cervical cancer screening in Spain and predictors of adherence.
    Martín-López R; Hernández-Barrera V; De Andres AL; Garrido PC; De Miguel AG; García RJ
    Eur J Cancer Prev; 2010 May; 19(3):239-45. PubMed ID: 20110817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in abnormal cancer screening results in the United States of America.
    Yabroff KR; Freedman A; Brown ML; Ballard-Barbash R; McNeel T; Taplin S
    J Med Screen; 2007; 14(2):67-72. PubMed ID: 17626704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for care related to follow-up of abnormal cancer screening tests: accuracy of patient report.
    Puleo E; Zapka JG; Goins KV; Yood MU; Mouchawar J; Manos M; Somkin C; Taplin S
    Eval Health Prof; 2005 Sep; 28(3):310-27. PubMed ID: 16123260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women.
    Suarez L; Pulley L
    J Natl Cancer Inst Monogr; 1995; (18):41-7. PubMed ID: 8562221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening.
    Yabroff KR; Kerner JF; Mandelblatt JS
    Prev Med; 2000 Oct; 31(4):429-39. PubMed ID: 11006069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to recommended health checks by women in mid-life: data from a prospective study of women across Australia.
    Byles J; Leigh L; Chojenta C; Loxton D
    Aust N Z J Public Health; 2014 Feb; 38(1):39-43. PubMed ID: 24494944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of citizenship status, acculturation, and health insurance in breast and cervical cancer screening among immigrant women.
    Echeverria SE; Carrasquillo O
    Med Care; 2006 Aug; 44(8):788-92. PubMed ID: 16862042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast and cervical cancer screening among Appalachian women.
    Hall HI; Uhler RJ; Coughlin SS; Miller DS
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):137-42. PubMed ID: 11815412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey.
    Yaren A; Ozkilinc G; Guler A; Oztop I
    Eur J Cancer Care (Engl); 2008 May; 17(3):278-84. PubMed ID: 18419631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social support and cervical and breast cancer screening in Argentinean women from a rural population.
    Gamarra CJ; Paz EP; Griep RH
    Public Health Nurs; 2009; 26(3):269-76. PubMed ID: 19386062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perception and experience of primary care physicians on Pap smear screening for women with intellectual disabilities: a preliminary finding.
    Lin JD; Sung CL; Lin LP; Liu TW; Lin PY; Chen LM; Chu CM; Wu JL
    Res Dev Disabil; 2010; 31(2):440-5. PubMed ID: 19939625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.